Minapharm Pharmaceuticals (CAI:MIPH) Change In Payables And Accrued Expense : E£0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Change In Payables And Accrued Expense?

Minapharm Pharmaceuticals's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was E£0 Mil. It means Minapharm Pharmaceuticals's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

Minapharm Pharmaceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was E£0 Mil. It means Minapharm Pharmaceuticals's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Minapharm Pharmaceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for Minapharm Pharmaceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Change In Payables And Accrued Expense Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

Change In Payables And Accrued Expense

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial			-	-	-	-	-

Minapharm Pharmaceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0 Mil.

Minapharm Pharmaceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines